Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enara Health vs LumiMeds

Enara Health
Graded #221

Lower grade

vs+3.299999999999997
LumiMeds
Graded #143

Higher grade

The verdict

LumiMeds takes it — 68.6/100 to 65.3/100.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +32
45
77
Dose & formulationLumiMeds +11
53
64
Clinical oversightEnara Health +10
92
82
Labs & monitoringEnara Health +32
85
53
FulfillmentEnara Health +1
66
65
Contract termsEven
55
55
Enara Health · left barLumiMeds · right bar

The numbers

MetricEnara HealthLumiMeds
WeighScore65.3/10068.6/100
GradeCC
Scorecard rank#221#143
SemaglutideNot disclosed$133/mo (starting dose, compounded)
TirzepatideNot disclosed$133/mo (starting dose, compounded)
Coverage6 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Enara Health

Graded #221 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) not compounded
  • Insurance-based with prior-auth coverage for over 65% of members
  • Board-certified obesity-medicine physicians
  • Comprehensive program: dietitian, coaching, metabolic and genetic testing
  • Established since 2015 with clinical track record

Where it loses points

  • Available in only six states via partner clinics
  • Requires in-network insurance; not a flat cash-pay option
  • Not a pure-telehealth nationwide service
  • Out-of-pocket cost varies by insurance coverage
  • No compounded budget alternative for the uninsured
LumiMeds

Graded #143 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard